Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

HO, DAVID

One or more keywords matched the following items that are connected to HO, DAVID

Item Type	Name
Academic Article	SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.
Academic Article	Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
Academic Article	Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus.
Academic Article	Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus.
Academic Article	Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
Academic Article	Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin.
Academic Article	Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
Academic Article	A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses.
Concept	Membrane Glycoproteins
Concept	Hemagglutinin Glycoproteins, Influenza Virus
Concept	Glycoproteins
Concept	Spike Glycoprotein, Coronavirus
Academic Article	Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529.
Academic Article	Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern.
Academic Article	Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
Academic Article	SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.
Academic Article	Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey.
Academic Article	Cryo-EM structure of the SARS-CoV-2 Omicron spike.
Academic Article	Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles.
Academic Article	Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.
Academic Article	Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.
Academic Article	An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses.
Academic Article	A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates.
Academic Article	Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.
Academic Article	Angiotensin converting enzyme 2 is a novel target of the ?-secretase complex.
Academic Article	Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2.
Academic Article	Antibody evasion properties of SARS-CoV-2 Omicron sublineages.
Academic Article	Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.
Academic Article	Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.
Academic Article	Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses.
Academic Article	Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Academic Article	Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.
Academic Article	Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes.
Academic Article	Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.
Academic Article	Impaired potency of neutralizing antibodies against cell-cell fusion mediated by SARS-CoV-2.
Academic Article	Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies.
Academic Article	Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75.
Academic Article	Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens.
Academic Article	Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains.
Academic Article	Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5.
Academic Article	SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1.
Academic Article	Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking.
Academic Article	Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike.

Search Criteria

Glycoproteins